News

Luc7, the blue group of proteins, against a background of human cells.

Splice of life

MIT News

The Burge lab has discovered a new type of control over RNA splicing, a process critical for gene expression. Appearing in a new Nature Communications paper, their study sheds light on how this control mechanism can go wrong—and serve as a potential therapeutic target—in acute myelogenous leukemias and other diseases.

Filter by

Filter by Title/Description

Filter by Topic

Filter by Year

Implantable Insulin Factory

MIT News

An implantable device from the Anderson and Langer Labs carries cells that produce insulin, plus a tiny oxygen-producing factory that keeps the cells healthy. The device, described in PNAS, could help control diabetes without the need for injections.

Anthrax Delivers

MIT News

Combining inspiration from nature with state-of-the-art machine learning and automation, the Pentelute Lab is inventing new chemistry platforms and techniques to develop therapies for cancer and beyond. To help solve biotechnology’s longstanding problem of delivering large and unwieldy molecules into cells, the lab hijacked the anthrax virus’s highly effective delivery system to transport antibody and peptide variants into cells to treat cancer.

Predicting Immunotherapy Response

MIT News

A Nature Genetics study from the Jacks Lab could help identify cancer patients who would benefit the most from immunotherapies called checkpoint blockade inhibitors. The researchers found in mouse models that measuring the diversity of mutations within a tumor generated much more accurate predictions of whether the treatment would succeed than measuring the overall number of mutations. If validated in clinical trials, this information could help doctors to better determine which patients will benefit from checkpoint blockade inhibitors.

Congratulations to the 2023 Amon Award Winners 

MIT Koch Institute

The Koch Institute at MIT is pleased to announce the winners of the 2023 Angelika Amon Young Scientist Award, Johanna Gassler (Max Planck Institute of Biochemistry, Germany) and Ruxandra-Andreea Lambuta (École Polytechnique Fédérale de Lausanne, Switzerland). Gassler and Lambuta, selected for their commitment to discovery science, will present their research at the Koch Institute on Thursday, November 2. 

New Medium Mimics Metabolism

MIT Koch Institute

Scientists often use human cancer cells grown in the lab to test potential anticancer drugs. Yet, the culture medium used in the lab does not accurately represent the nutrients present in the body, leading to discrepancies in drug responses. In a study published in Cell Chemical Biology, the Vander Heiden Laboratory has developed a new culture medium that better mimics physiological nutrient levels, supports the proliferation of diverse cancer cell lines and is amenable to high-throughput screening. The group found that drugs targeting cancer cell metabolism showed the most significant differences in effectiveness between standard cell culture medium and theirs. These findings may help researchers understand why some drugs that worked well in the lab fail in real-life situations and provides a new tool for screening potential anticancer agents, especially those targeting cancer cell metabolism.

Better, Cheaper, Faster RNA Vaccine

MIT News

The Anderson Lab has engineered key vaccine components—both the nanoparticles that deliver the Covid-19 antigen, and the antigen itself—to boost immune response without a separate adjuvant. Such RNA vaccines could help reduce costs, reduce dosage needed, and potentially induce longer-lasting immunity. The vaccine may produce a strong enough response to be delivered intranasally.
 

KI Postdocs Named Banting Fellows

Government of Canada

Cheers to Erika Wang (Langer Lab and Jaklenec Group) and Binbin Ying (Langer and Traverso Labs) on being named Banting Postdoctoral Fellows by the Canadian government. The Banting Fellowship is a highly prestigious award that recognizes scholars who demonstrate outstanding potential to contribute positively to Canada's economic, social, and research-driven advancement. 

On the Shortlist for Cancer Grand Challenges Funding

Cancer Research UK

KI members Michael Birnbaum, Ömer Yilmaz, Brandon DeKosky and Regina Barzilay, as well as their MIT colleague Seychelle Vos, have been shortlisted by Cancer Research UK and the National Cancer Institute for the Cancer Grand Challenges as part of teams MATCHMAKERS, PROSPECT and KOODAC. If selected, these global, interdisciplinary teams will receive up to $25m to make radical progress against some of cancer’s toughest challenges.

Soto-Feliciano Named AACR 2023 Gertrude B. Elion Cancer Research Award Grantee

American Association for Cancer Research

Congratulations to Yadira Soto-Feliciano on receiving the AACR 2023 Gertrude B. Elion Cancer Research Award. She will use the award to support her work revealing cancer epigenomes through the lens of chromatin adaptor proteins. "The 2023 AACR Gertrude B. Elion Cancer Research Award is important to me because it recognizes the immense value of fundamental biomedical research in combating cancer," remarked Soto-Feliciano. "This prestigious honor inspires me to continue my pursuit of groundbreaking discoveries, ultimately aiming to make a meaningful impact in the lives of cancer patients."  

Paying It Forward

MIT Spectrum

As the first person in his family to attend college, Digbijay (Jay) Mahat had the enthusiastic support of his father, who wanted his firstborn to receive the education he had not. Mahat vowed to seek the highest degree possible in what he considered the most prestigious discipline—science—to stay true to his father’s dreams as well as his own. Today, Mahat is a new father and an accomplished cancer researcher who considers humanity and public service to be every bit as important as education and science. Guided by advisors such as MIT Institute Professor Phillip Sharp, Mahat became a mentor with the belief that education can shape not only students’ professional trajectories but also the people they become. “The soft skills of working in a group, the culture of sharing resources, and compassion towards each other mold us into better citizens,” says Mahat, a 2021 recipient of the Peter Karches Mentorship Prize at the MIT Koch Institute.